Pulsenmore Wins FDA Approval for Home Ultrasound Pregnancy Device
Israeli medical device company Pulsenmore has received marketing approval from the US Food and Drug Administration (FDA) for its home ultrasound device for pregnant women.
The company already markets the device in Israel through an agreement with Clalit Health Services and has been awaiting approval for the US market. Prior to trading, the company had a market cap of NIS 195 million.
Our device has been approved in the 510k de novo pathway. This means that there is no precedent for such a product in the US, and anyone who wants to enter the category now will have to compare themselves to a control group similar to the one we were asked to compare our treatment to.
said Elazar Sonnenschein.
Author's summary: Pulsenmore gets FDA nod.
More News
- DJ Carey Sentenced for Fraud
- Russell M. Nelson, president of The Church of Jesus Christ of Latter-day Saints, pushed it away from ‘Mormon'
- Travel: Going eye to eye with belugas in Churchill, Manitoba
- Jennifer Lawrence Hits an Afterparty in a Lacy Look
- Knickerbocker to Host Special Screening of “The Most Precious of Cargoes” Nov. 13–14
- Kimberly-Clark to Acquire Kenvue, Creating a $32B Global Health and Wellness Leader
- Kimberly-Clark to Acquire Tylenol Maker Kenvue in $48.7 Billion Deal, Creating Global Consumer Health Giant